Results 91 to 100 of about 4,236 (180)

Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. Special Article: Advanced therapy medicinal products in Brazil: regulatory panorama. [PDF]

Hematol Transfus Cell Ther, 2021
Silva Junior JB, Rodrigues E Silva AA, Melo FCC, Kumoto MC, Parca RM.   +4 more
europepmc   +1 more source

Guidelines on sickle cell disease: primary stroke prevention in children and adolescents. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines project: Associação Médica Brasileira - 2021. [PDF]

Hematol Transfus Cell Ther, 2022
Loggetto SR, Veríssimo MPA, Darrigo-Junior LG, Simões RDS, Bernardo WM, Braga JAP.   +5 more
europepmc   +1 more source

Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. II: CAR-T cell therapy for patients with CD19+ acute lymphoblastic leukemia. [PDF]

Hematol Transfus Cell Ther, 2021
Seber A, de CastroJunior CG, Kerbauy LN, Hirayama AV, Bonfim C, Fernandes JF, Souza M, Schafell R, Nabhan S, Loggetto SR, Simões BP, Rocha V, de Lima M, Guerino-Cunha RL, Bittencourt H.   +14 more
europepmc   +1 more source

Terapia celular CAR-T

, 2019
The CAR-T has been latest attention focus for being an innovative therapy with excellent results at times no other treatment had and for being an immunotherapy based on the patient's own immunologic system. Countless studies are happening at the moment to develop more and new CAR-Ts with better results and less adverse effects.
openaire   +1 more source

Liver Fibrosis and Mechanisms of the Protective Action of Medicinal Plants Targeting Inflammation and the Immune Response

International Journal of Inflammation, 2015
Inflammation is a central feature of liver fibrosis as suggested by its role in the activation of hepatic stellate cells leading to extracellular matrix deposition.
Florent Duval, Jorge E. Moreno-Cuevas, María Teresa González-Garza, Carmen Maldonado-Bernal, Delia Elva Cruz-Vega   +4 more
doaj   +1 more source

Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. I: Structuring centers for the multidisciplinary clinical administration and management of CAR-T cell therapy patients. [PDF]

Hematol Transfus Cell Ther, 2021
Clé DV, Hirayama AV, Alencar AJ, Costa LJ, Feliciano JVP, Mattos ER, Cordeiro AC, Salvino MA, Barros GMN, de Lima M, Scheinberg P, Guerino-Cunha RL.   +11 more
europepmc   +1 more source

Effects of MSC Coadministration and Route of Delivery on Cord Blood Hematopoietic Stem Cell Engraftment

Cell Transplantation, 2013
Hematopoietic stem cell transplantation (HSCT) using umbilical cord blood (UCB) progenitors is increasingly being used. One of the problems that may arise after UCB transplantation is an impaired engraftment.
S. Carrancio, C. Romo, T. Ramos, N. Lopez-Holgado, S. Muntion, H. J. Prins, A. C. Martens, J. G. Briñón, J. F. San Miguel, M. C. Del Cañizo, F. Sanchez-Guijo   +10 more
doaj   +1 more source

Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. III: anti-CD19 CAR-T cell therapy for patients with non-Hodgkin lymphoma. [PDF]

Hematol Transfus Cell Ther, 2021
Alencar AJ, Hirayama AV, Clé DV, Salvino MA, Perini G, Arrais C, Baiocchi O, Palma LC, Colturato I, Vaz J, Chiattone R, de Lima M, Filho JS, Nabhan S, Rocha V, Guerino-Cunha RL, Chiattone CS.   +16 more
europepmc   +1 more source

UEG Week 2025 Oral Presentations

United European Gastroenterology Journal, Volume 13, Issue S8, Page S7-S188, October 2025.
wiley   +1 more source

Terapias celulares en Oncología [PDF]

Oncología (Barcelona), 2006
García Castro, J., Ramírez Orellana, M., Pérez Martínez, A., Madero López, L.   +3 more
openaire   +3 more sources